Skip to content

Drug interactions

Etravirine + Lapatinib

Severity: Moderate

Etravirine and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etravirine is a CYP3A4 inducer and may lower lapatinib exposure, reducing efficacy. Lapatinib may in turn raise etravirine levels through CYP3A4 inhibition, though the effect is likely modest.

What this interaction means in plain words

Etravirine and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Etravirine belongs to Anti Virals; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Etravirine induces CYP3A4 and lapatinib inhibits CYP3A4, altering clearance of each other.

What to do

Monitor for reduced lapatinib response and consider a dose increase if an inducer is unavoidable. Monitor antiretroviral efficacy and tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etravirine and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etravirine with Lapatinib?

MediHelp rates the interaction as moderate. Etravirine and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Etravirine is a CYP3A4 inducer and may lower lapatinib exposure, reducing efficacy. Lapatinib may in turn raise etravirine levels through CYP3A4 inhibition, though the effect is likely modest.

How serious is the interaction between Etravirine and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced lapatinib response and consider a dose increase if an inducer is unavoidable. Monitor antiretroviral efficacy and tolerability.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in